WINDTREE THERAPEUTICS, INC.Stock Option Agreement • April 3rd, 2020 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 3rd, 2020 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Amendment No. 1 to the Securities Purchase Agreement (the “Amendment”) is made this 20th day of February, 2020, by and among Windtree Therapeutics, Inc., a Delaware corporation (the “Company”) and the purchasers of the Securities listed on the signature pages hereto (collectively, the “Holders”). Capitalized terms used in this Amendment that are not otherwise defined or referenced herein shall have their respective meanings set forth in the Securities Purchase Agreement (as defined herein).
EMPLOYMENT AGREEMENTEmployment Agreement • April 3rd, 2020 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • Pennsylvania
This Employment Agreement (the “Agreement") is made as of March 1, 2020, by and between Windtree Therapeutics, Inc., a Delaware corporation (the "Company"), and Eric Curtis ("Executive"), subject to the terms and conditions defined in this Agreement.
